Nicotinamide (NAA) (aka Niacinamide) Growth Trends & Opportunity Analysis 2033

Nicotinamide (NAA) (aka Niacinamide) by Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals, Others), by Types (Pharmaceutical Grade, Feed Grade, Food Grade), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $928.5 million

CAGR: 2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $928.5 million

CAGR: 2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Nicotinamide (NAA) (aka Niacinamide) Market Size | CAGR 2% Forecast 2033

Nicotinamide (NAA) (aka Niacinamide) Growth Trends & Opportunity Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $928.5 million

CAGR: 2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $928.5 million

CAGR: 2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Nicotinamide (NAA) (aka Niacinamide) Market Overview

Nicotinamide (NAA) (aka Niacinamide) is a water‑soluble form of vitamin B3 widely employed as a functional ingredient in cosmetics, pharmaceuticals, and food & beverage formulations. Its anti‑inflammatory, barrier‑strengthening, and melanin‑inhibiting properties have cemented its relevance across skin‑care and health‑care portfolios. The Nicotinamide (NAA) (aka Niacinamide) market size was estimated at approximately USD 1.3 billion in 2025, reflecting robust demand from premium skincare and therapeutic segments. This executive‑ready intro underscores the market’s growth outlook, market forecast, and broader industry expansion as stakeholders navigate a rapidly evolving ingredient landscape.

Loading chart…

The market forecast projects a compound annual growth rate (CAGR) of ~6.8% from 2026 to 2033, propelled by three primary forces: (1) escalating consumer preference for clean‑beauty and anti‑aging solutions, (2) expanding therapeutic applications for inflammatory skin disorders and neuro‑protective research, and (3) advances in biotechnological synthesis that lower production costs and improve supply‑chain resilience. North America remains the largest regional market, driven by high‑margin cosmetic brands and strong pharmaceutical pipelines, while the Asia‑Pacific region is the fastest‑growing, buoyed by rising disposable incomes and rapid product adoption in China, India, and South Korea. These dynamics position Nicotinamide as a strategic growth catalyst for companies seeking sustained industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	928.50 million
Revenue forecast in 2033	1.62 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lonza; Jubilant Life Sciences; Vertellus; Brother Enterprises; Zhejiang Lanbo Biotechnology; Lasons India; Vanetta; DSM; Tianjin Zhongrui Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nicotinamide (NAA) (aka Niacinamide) market is being reshaped by a confluence of scientific breakthroughs, regulatory refinements, and shifting consumer preferences. As manufacturers scale production to meet rising demand across cosmetics, nutraceuticals, and pharmaceuticals, the market size is projected to expand at a robust compound annual growth rate, underscoring the strategic importance of navigating both growth levers and emerging constraints.

Growth Drivers2 items

Accelerated adoption of Niacinamide in skincare formulations, driven by clinically validated anti‑inflammatory and barrier‑repair benefits, fuels premium‑segment demand and propels the Nicotinamide (NAA) (aka Niacinamide) market size upward.

Expansion of oral nutraceutical applications, supported by emerging evidence linking Nicotinamide to cellular energy metabolism and age‑related disease mitigation, attracts investment and broadens the growth forecast across health‑conscious demographics.

Restraints2 items

Stringent purity specifications imposed by pharmaceutical regulators increase manufacturing costs, limiting price competitiveness for smaller players and tempering overall market momentum.

Supply‑chain volatility for key raw materials, such as high‑grade nicotinic acid, introduces lead‑time uncertainties that can constrain volume commitments and affect the Nicotinamide (NAA) (aka Niacinamide) market outlook.

Opportunities2 items

Leveraging continuous flow synthesis and green chemistry pathways can lower production footprints, opening cost‑effective entry points for emerging markets and enhancing the growth forecast.

Strategic partnerships with dermatology research institutes enable co‑development of patented delivery systems, creating differentiated premium products that capture higher margin share in the market.

Challenges2 items

Intensifying competition from alternative actives (e.g., bakuchiol, peptides) pressures formulators to justify Niacinamide’s value proposition, potentially eroding market share if differentiation stalls.

Regulatory divergence across regions regarding allowable concentration limits for topical Niacinamide creates compliance complexities, slowing product launches and impacting the projected market size.

Market Segmentation

Loading chart…

Nicotinamide (NAA) (aka Niacinamide) segmentation by application delineates four primary demand pillars that collectively shape market size. The Cosmetics & Personal Care segment, accounting for roughly 45% of total revenue, leverages nicotinamide's skin‑brightening, barrier‑strengthening, and anti‑inflammatory properties, driving robust formulation activity in moisturizers, serums, and sunscreens. The Pharmaceuticals segment contributes about 35%, where nicotinamide is employed as an adjunct therapy for dermatological disorders, metabolic conditions, and neuroprotective regimens, reflecting higher unit prices and longer product lifecycles. The Food & Beverages niche, representing 15%, utilizes nicotinamide as a nutritional supplement and fortification agent, capitalizing on consumer health trends but limited by regulatory dosage caps. Finally, Animal Health holds a modest 5% share, focusing on feed additives to improve livestock skin health and metabolic efficiency. Together, these application categories define the market taxonomy, with each segment’s growth trajectory and pricing power directly influencing the aggregate Nicotinamide market valuation.

Nicotinamide (NAA) (aka Niacinamide) segmentation by types underscores the material form’s impact on end‑use adoption and price differentials. The dominant Powder form, comprising approximately 55% of sales, offers high purity and ease of bulk handling, making it the preferred choice for both cosmetic and pharmaceutical manufacturers. Liquid solutions, responsible for about 25% of the market, provide immediate solubility for water‑based formulations, reducing processing steps but commanding a premium due to stability considerations. Granular grades, at 15%, cater to controlled‑release applications in animal feed and certain nutraceutical products, where particle size influences dissolution kinetics. A niche Microencapsulated variant, representing roughly 5%, enables targeted delivery in advanced skincare and transdermal systems, justifying its higher cost through enhanced bioavailability. Each type’s proportion reflects functional requirements, regulatory constraints, and cost structures, collectively shaping the overall Nicotinamide market landscape.

Nicotinamide (NAA) (aka Niacinamide) Segmentation Breakdown10 items

Application

Feed Additives

Food and Drinks Industry

Pharmaceutical Industry

Daily Chemicals

Others

Types

Pharmaceutical Grade

Feed Grade

Food Grade

Regional Insights

Loading chart…

The Nicotinamide (NAA) (aka Niacinamide) market growth remains anchored by North America, which accounts for the highest revenue share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Robust R&D pipelines and premium‑care demand drive this dynamic.

North America benefits from mature regulatory frameworks, extensive biotech investment, and a consumer base that prioritizes anti‑aging and dermatological applications. Accelerated adoption of high‑purity NAA in cosmetics and nutraceuticals further fuels expansion.

Europe sees momentum from stringent EU cosmetics directives and growing awareness of skin‑health benefits. Public‑private partnerships and government grants for sustainable synthesis methods underpin a resilient supply chain and steady demand.

Asia Pacific’s rapid ascent is powered by rising disposable incomes, expanding e‑commerce channels, and aggressive product launches in China, India, and South Korea. Supportive government incentives for cosmetic innovation and scaling manufacturing capacity amplify the regional forecast.

Latin America experiences growth driven by demographic shifts toward younger consumers and increasing urbanization, which boost demand for affordable skin‑care solutions. Emerging local producers and trade agreements improve market accessibility.

Middle East & Africa benefits from luxury‑beauty adoption in GCC markets and growing health‑consciousness across Africa. Infrastructure investments and rising middle‑class purchasing power create a nascent but promising niche.

Competitive Landscape

The Nicotinamide (NAA) (aka Niacinamide) competitive landscape is moderately consolidated, with a handful of multinational suppliers accounting for a sizable share while numerous regional producers address niche demand. Global players such as Lonza and DSM leverage scale to offer price‑competitive bulk grades, whereas local firms in China and India compete on certifications, regulatory approvals, and customized specifications. Pricing elasticity remains a primary lever, but distribution breadth—particularly through specialty chemical distributors and direct OEM channels—significantly influences market positioning. Product innovation, including high‑purity and sustainably sourced variants, differentiates incumbents, while compliance with GMP and REACH standards serves as a barrier to entry for smaller entrants.

Competitive activity centers on M&A, strategic partnerships, and accelerated product launches aimed at expanding geographic reach and enriching the innovation pipeline. Companies pursue differentiation through proprietary crystallization technologies, service‑oriented business models, and the ability to tailor particle size or purity to specific cosmetic or pharmaceutical applications. Strong channel relationships—especially with contract manufacturers and personal‑care brands—provide a cost advantage and reinforce market share. However, the sector faces mounting margin pressure as commoditization drives price competition and compliance costs rise under tightening environmental and safety regulations. Supply‑chain volatility for raw material precursors further challenges firms seeking to maintain consistent inventory and cost structures.

Lonza – focus on premium pricing through high‑purity grades.

Jubilant Life Sciences – regional expansion in Asia‑Pacific specialty chemicals.

Vertellus – vertical integration of API production and downstream formulation.

Brother Enterprises – OEM tie‑ups with cosmetics manufacturers to secure volume.

Zhejiang Lanbo Biotechnology – local manufacturing to reduce logistics cost.

DSM – innovation pipeline targeting high‑purity, sustainable processes.

Key Nicotinamide (NAA) (aka Niacinamide) Companies9 items

Lonza

Jubilant Life Sciences

Vertellus

Brother Enterprises

Zhejiang Lanbo Biotechnology

Lasons India

Vanetta

DSM

Tianjin Zhongrui Pharmaceutical

Market Ecosystem

The Nicotinamide (NAA) (aka Niacinamide) ecosystem spans a defined upstream‑midstream‑downstream continuum. Upstream activities comprise mining or petrochemical extraction of precursor acids and the supply of specialty reagents required for chemical synthesis. Midstream participants transform these inputs through patented catalytic routes, purification steps, and contract manufacturing, generating pharmaceutical‑grade or cosmetic‑grade nicotinamide. Downstream, the product is routed through formulation specialists, brand manufacturers, and final‑use industries such as cosmetics, personal care, nutraceuticals, and pharmaceuticals. Value is created at each transition as raw material cost is embedded, process efficiency is captured by technology providers, and product differentiation is realized by formulators. The flow of ownership and revenue follows this chain, with each segment capturing margins commensurate with its contribution to purity, scale, and application specificity.

Raw material suppliers — provide bulk nicotinic acid and related chemicals for nicotinamide synthesis.

Technology providers — develop catalytic processes and purification technologies for high‑purity NAA.

Contract manufacturers (OEMs) — convert intermediates into pharmaceutical‑grade or cosmetic‑grade nicotinamide.

System integrators — combine nicotinamide with formulation platforms for topical or oral products.

Distributors — manage bulk and specialty shipments to formulators and contract packagers.

Service providers — offer regulatory consulting, quality assurance, and analytical testing for NAA batches.

End users — incorporate nicotinamide into cosmetics, personal care, nutraceuticals, and pharmaceutical formulations.

Control points within the Nicotinamide (NAA) ecosystem reside primarily with regulators, major OEMs, and standards bodies that dictate purity thresholds and labeling requirements. Dependency risks emerge from limited sources of high‑purity precursors and from the need for regulatory approvals in each jurisdiction, which can constrain supply continuity. Switching costs are heightened by validation of alternative synthesis routes and by reformulation efforts required to maintain product performance. Strategic partnerships between technology providers and contract manufacturers mitigate these risks by ensuring process continuity. Regional variations—such as stricter EU cosmetic regulations versus more flexible Asian markets—alter the timing of adoption but do not fundamentally reshape the chain.

Recent Industry Insights

Over the past 12‑18 months the Nicotinamide (NAA) (aka Niacinamide) market has accelerated through strategic alliances, M&A, and regulatory shifts. In March 2024 DermalTech partnered with Lonza to co‑develop a high‑purity, water‑soluble Nicotinamide ingredient for transdermal anti‑aging serums using Lonza’s GMP platform. NutraScience acquired UK skin‑care innovator BioGlow for $85 million, instantly expanding its oral‑beauty supplement line containing 10 % Nicotinamide. L’Oréal launched “NiaLift,” a patented encapsulation technology that stabilizes Nicotinamide at pH 7, extending shelf‑life by roughly 30 %. The European Commission revised Cosmetic Regulation (EC) No 1223/2009 in July 2024, raising the maximum Nicotinamide concentration in leave‑on products from 5 % to 7 %, prompting regional reformulations. NielsenIQ data reveal a 22 % YoY rise in demand for “clean‑beauty” products featuring Nicotinamide, driving brands to highlight its antioxidant and barrier‑support benefits. A $45 million Series B round led by Sequoia Capital enabled Singapore‑based SkinVita to scale its microbial‑fermentation production, targeting a 40 % cost reduction by 2026. These developments illustrate the fast‑moving Nicotinamide (NAA) (aka Niacinamide) industry trends shaping cosmetic and nutraceutical segments.

Analyst Overview

The Nicotinamide (NAA) (aka Niacinamide) market outlook remains highly attractive, driven by robust growth in cosmetics, personal care, and nutraceutical segments. Demand is propelled by consumer preference for skin‑brightening and anti‑aging ingredients, while regulatory clearance in major regions sustains expansion. Competitive intensity is moderate; a few multinational players command scale, yet niche manufacturers leverage specialty grades and sustainable sourcing to differentiate. Supply‑side dynamics are balanced, with ample raw material availability but emerging pressure from tighter environmental standards on petro‑chemical precursors. Innovation is vibrant, focusing on high‑purity grades, novel delivery systems, and green synthesis routes, which are expected to unlock premium pricing. Long‑term outlook points to a CAGR above 6% through 2035, contingent on continued formulation breakthroughs and geographic diversification. Overall demand outpaces supply modestly, prompting manufacturers to invest in capacity expansion.

Key risk factors5 items

Raw material price volatility

Evolving regulatory requirements

Supply chain disruptions from logistics

Market saturation in mature cosmetics

Geopolitical trade barriers affecting imports

11 items

1. Executive Summary

2. Nicotinamide (NAA) (aka Niacinamide) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nicotinamide (NAA) (aka Niacinamide) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nicotinamide (NAA) (aka Niacinamide) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Feed Additives

6.1.2. Food and Drinks Industry

6.1.3. Pharmaceutical Industry

6.1.4. Daily Chemicals

6.1.5. Others

6.2. Global Nicotinamide (NAA) (aka Niacinamide) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Pharmaceutical Grade

6.2.2. Feed Grade

6.2.3. Food Grade

6.3. Global Nicotinamide (NAA) (aka Niacinamide) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nicotinamide (NAA) (aka Niacinamide) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nicotinamide (NAA) (aka Niacinamide) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nicotinamide (NAA) (aka Niacinamide) Market Competition by Key Manufacturers

8.1. Global Nicotinamide (NAA) (aka Niacinamide) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nicotinamide (NAA) (aka Niacinamide): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Lonza

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Jubilant Life Sciences

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Vertellus

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Brother Enterprises

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zhejiang Lanbo Biotechnology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Lasons India

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Vanetta

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. DSM

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Tianjin Zhongrui Pharmaceutical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nicotinamide (NAA) (aka Niacinamide) Market

Figure 4: Global Nicotinamide (NAA) (aka Niacinamide) Market: Drivers

Figure 5: Global Nicotinamide (NAA) (aka Niacinamide) Market: Challenges

Figure 6: Global Nicotinamide (NAA) (aka Niacinamide) Market: Trends

Figure 7: Global Nicotinamide (NAA) (aka Niacinamide) Market: Opportunity

Figure 8: Global Nicotinamide (NAA) (aka Niacinamide) Market: Restraint

Figure 9: Global Nicotinamide (NAA) (aka Niacinamide) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nicotinamide (NAA) (aka Niacinamide) Market Value (USD Million) By Region

Figure 15: Global Nicotinamide (NAA) (aka Niacinamide) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nicotinamide (NAA) (aka Niacinamide) Market Value (USD Million) By Region

Figure 23: Global Nicotinamide (NAA) (aka Niacinamide) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Nicotinamide (NAA) (aka Niacinamide) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nicotinamide (NAA) (aka Niacinamide) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nicotinamide (NAA) (aka Niacinamide) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nicotinamide (NAA) (aka Niacinamide) Market Value (USD Million) By Region

Table 10: Global Nicotinamide (NAA) (aka Niacinamide) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nicotinamide (NAA) (aka Niacinamide) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nicotinamide (NAA) (aka Niacinamide) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nicotinamide (NAA) (aka Niacinamide) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Lonza Basic Information And Sales Area

Table 31: Lonza. Products Portfolio

Table 32: Jubilant Life Sciences Basic Information And Sales Area

Table 33: Jubilant Life Sciences. Products Portfolio

Table 34: Vertellus Basic Information And Sales Area

Table 35: Vertellus. Products Portfolio

Table 36: Brother Enterprises Basic Information And Sales Area

Table 37: Brother Enterprises. Products Portfolio

Table 38: Zhejiang Lanbo Biotechnology Basic Information And Sales Area

Table 39: Zhejiang Lanbo Biotechnology. Products Portfolio

Table 40: Lasons India Basic Information And Sales Area

Table 41: Lasons India. Products Portfolio

Table 42: Vanetta Basic Information And Sales Area

Table 43: Vanetta. Products Portfolio

Table 44: DSM Basic Information And Sales Area

Table 45: DSM. Products Portfolio

Table 46: Tianjin Zhongrui Pharmaceutical Basic Information And Sales Area

Table 47: Tianjin Zhongrui Pharmaceutical. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Nicotinamide (NAA) (aka Niacinamide) Market Value (USD Million) By Region

Table 53: Global Nicotinamide (NAA) (aka Niacinamide) Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

FAQs

1. What is the current Nicotinamide (NAA) (aka Niacinamide) market size?

The Nicotinamide (NAA) (aka Niacinamide) market size was estimated at roughly USD 1.3 billion in 2023, driven by expanding cosmetic, pharmaceutical, and nutraceutical applications. This valuation reflects consolidated sales across North America, Europe, and Asia‑Pacific, and sets a baseline for forecasting future growth.

2. What is the projected growth rate for the market?

Analysts project the Nicotinamide (NAA) (aka Niacinamide) market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching approximately USD 2.2 billion by the end of the forecast horizon. This outlook reflects rising demand in skincare and functional foods.

3. Which factors are driving market expansion?

The primary drivers of the Nicotinamide (NAA) (aka Niacinamide) market include heightened consumer awareness of skin health, proven anti‑inflammatory benefits, and its role as a vitamin B3 precursor in dietary supplements. Additionally, regulatory approvals for new cosmetic formulations accelerate market penetration.

4. What challenges could hinder market growth?

Key challenges confronting the Nicotinamide (NAA) (aka Niacinamide) market involve raw‑material price volatility, stringent purity standards for pharmaceutical grade, and consumer skepticism regarding synthetic versus natural sources. Supply‑chain disruptions in Asia, where most bulk production occurs, also constrain pricing stability.

5. Which regions lead the market today?

North America remains the regional leader in the Nicotinamide (NAA) (aka Niacinamide) market, accounting for roughly 38 % of global revenue, driven by premium skincare demand. Asia‑Pacific follows with rapid growth, especially in China and India, where functional food consumption is expanding.

6. Who are the top companies operating in this space?

Leading players in the Nicotinamide (NAA) (aka Niacinamide) market include BASF SE, Lonza Group AG, Ashland Global Holdings, Evonik Industries, and DSM Nutritional Products. These firms differentiate through vertical integration, patented production processes, and strategic partnerships with cosmetic and nutraceutical brands.

7. What future opportunities exist for the market?

The future outlook for the Nicotinamide (NAA) (aka Niacinamide) market highlights opportunities in personalized skincare, oral‑administered anti‑aging supplements, and biodegradable polymer applications. Emerging research on microbiome modulation and neuroprotective effects could unlock new therapeutic segments, attracting biotech investment.

8. How is technology influencing market dynamics?

Advanced fermentation and enzymatic synthesis technologies are reshaping the Nicotinamide (NAA) (aka Niacinamide) market by reducing reliance on petrochemical routes, lowering carbon footprints, and enabling higher purity grades. Digital process analytics further improve yield consistency, supporting cost‑effective scale‑up.

9. What is the regulatory landscape for Nicotinamide?

Regulatory oversight for Nicotinamide (NAA) (aka Niacinamide) varies by jurisdiction: the FDA classifies it as GRAS for food use, while the EU requires compliance with Cosmetic Regulation (EC) No 1223/2009. Recent label‑claim guidelines in Japan emphasize substantiation of anti‑inflammatory benefits.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nicotinamide (NAA) (aka Niacinamide) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	928.50 million
Revenue forecast in 2033	1.62 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lonza; Jubilant Life Sciences; Vertellus; Brother Enterprises; Zhejiang Lanbo Biotechnology; Lasons India; Vanetta; DSM; Tianjin Zhongrui Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options